Event Concept

This year’s  GASB SynBio World Cafe: „What stops the SynBio revolution in Germany“ focuses on the different aspects that SynBio Startups are facing. The proven concept of the SynBio World Cafe aims to bridge between the academic and industrial SynBio world and to further connect them to stakeholders from the legislation. The mixed World Cafe participants range from academics, entrepreneurs, industry representatives, venture capitalists to legislators. They will engage in discussion about different topics: funding, entrepreneurial spirit, politics & governing, patents & regulations, as well as laboratory access & automation. Between the different discussion sessions, SynBio stakeholders will give short inspirational talks to nucleate discussions.

Besides talks and group discussions, there will be the possibility for virtual networking.  

The SynBio World Cafe will be closing with a quick wrap up from the different topic tables that will be the base for a call of action prepared by GASB and the Hightech-Forum.

Group Discussion Topics


Startups in SynBio require significant financial investments since research and proof of principle studies are needed before market access. What are the funding options? What is the bottleneck of fundraising? Do we need more venture and risk capital to boost the SynBio industry in Germany and beyond?


In Germany, the percentage of entrepreneurs who are SynBio graduates is limited compared to other countries. Is our academic education system not teaching creative and entrepreneurial thinking? Is it our cultural storytelling? What do we need to do to change the spirit to foster the founding of SynBio startups in Germany?


The goal is a green economy (bioeconomy) that the German government announced earlier this year! Why does the seed of the future bioeconomy - SynBio startups- not lift off? What needs to change in governing and politics to foster the rise of SynBio Startups MADE IN GERMANY?

Patents & Regulations

First, the patent, then you can found a company! Is this true for startups in SynBio? Are the current patent arguments a burden or a benefit? What are the regulatory bottlenecks for a SynBio product to be launched? Do we need a change in current regulations to support the upcoming SynBio industry?

Automation & Digitalization

Most of the SynBio startups require early and easy to professionally equipped laboratories. Setting up a functional laboratory might be the most prominent first investment for SynBio startups. Do we need more open labs? A startup bench in each academic lab, or will automation solve the problem, and we will have online accessible fully automated SynBio foundries where all experiments can be conducted?